Evidence map›Paper›PMID 37119825›Full record

ArticleThe lancet. HIV2023

The HIV care continuum for sexually active transgender women in three metropolitan municipalities in South Africa: findings from a biobehavioural survey 2018-19.

Allanise Cloete, Musawenkosi Mabaso, Helen Savva, L Leigh-Ann van der Merwe, Dhee Naidoo, Zaino Petersen, Zamakayise Kose, Jacqueline Mthembu, Sizulu Moyo, Donald Skinner and 5 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in The lancet. HIV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. South African harm reduction guideline for chemsex.Southern African journal of HIV medicine · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Allanise CloeteHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa. Electronic address: acloete@hsrc.ac.za.
Musawenkosi MabasoHuman and Social Capabilities Division, Human Sciences Research Council, Durban, South Africa.
Helen SavvaPrevention Branch, CDC, Pretoria, South Africa.
L Leigh-Ann van der MerweSocial, Health, and Empowerment Feminist Collective of Transgender Women of Africa, East London, South Africa.
Dhee NaidooDepartment of Anthropology and Archaeology, University of Pretoria, Pretoria, South Africa; The Durban LGBTI Community and Health Centre, Durban, KwaZulu-Natal, South Africa.
Zaino PetersenHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa.
Zamakayise KoseResearch Support Department, North-West University, Potchefstroom, South Africa.
Jacqueline MthembuHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa.
Sizulu MoyoHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Donald SkinnerSchool of Public Health, Stellenbosch University, Stellenbosch, South Africa.
Sean JoosteHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa.
Ian E FellowsHealth Informatics, Data Management, and Statistics Branch, Division of Global HIV and TB, CDC, Atlanta, GA, USA.
Ray W ShiraishiHealth Informatics, Data Management, and Statistics Branch, Division of Global HIV and TB, CDC, Atlanta, GA, USA.
Shaalula L MwandingiMinistry of Health and Social Services, Windhoek, Namibia.
Leickness C SimbayiHuman and Social Capabilities Division, Human Sciences Research Council, Cape Town, South Africa; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Human Sciences Research Council · ZAMinistry of Health and Social Services · NANorth-West University · ZAStellenbosch University · ZAUniversity of Cape Town · ZAUniversity of Pretoria · ZA

Funding

PEPFAR
6 · The paper itself

Abstract

backgroundDespite high HIV prevalence in transgender women in sub-Saharan Africa, to our knowledge no study presents data across the HIV care continuum for this population in the region. The aim of this study was to estimate HIV prevalence and present data to develop the HIV care continuum indicators for transgender women in three South African metropolitan municipalities.

methodsBiobehavioural survey data were collected among sexually active transgender women in the metropolitan municipalities of Johannesburg, Buffalo City, and Cape Town, South Africa. Transgender women (aged ≥18 years, self-reporting consensual sex with a man in the 6 months before the survey) were recruited using respondent-driven sampling (RDS). An interviewer-administered questionnaire was used to determine awareness of HIV status; blood specimens were collected on dried blood spots to test for HIV antibodies, antiretroviral treatment (ART) exposure, and viral load suppression. Population-based estimates of HIV 95-95-95 cascade indicators were derived by use of individualised RDS weights with RDS Analyst software. Multivariate stepwise backward logistic regression modelling was used to determine factors associated with each cascade indicator. All eligible participants were included in the final analysis.

findingsBetween July 26, 2018, and March 15, 2019, we enrolled 887 sexually active transgender women: 323 in Johannesburg, 305 in Buffalo City, and 259 in Cape Town. HIV prevalence was highest in Johannesburg where 229 (74·1%) of 309 tests were positive (weighted prevalence estimate 63·3%, 95% CI 55·5-70·5), followed by Buffalo City where 121 (43·7%) of 277 were positive (46·1%, 38·7-53·6), and then Cape Town where 122 (48·4%) of 252 were positive (45·6%, 36·7-54·7). In Johannesburg, an estimated 54·2% (95% CI 45·8-62·4) of transgender women with HIV knew their positive status, in Cape Town this was 24·2% (15·4-35·8), and in Buffalo City this was 39·5% (27·1-53·4). Among those who knew their status, 82·1% (73·3-88·5) in Johannesburg, 78·2% (57·9-90·3) in Cape Town, and 64·7% (45·2-80·2) in Buffalo City were on ART. Of those on ART, 34·4% (27·2-42·4) in Johannesburg, 41·2% (30·7-52·6) in Cape Town, and 55·0% (40·7-68·4) in Buffalo City were virally suppressed.

interpretationInnovative strategies are needed to inform efforts to diagnose and to treat transgender women living with HIV promptly to achieve viral load suppression. Differentiated HIV services tailored to transgender women of race groups other than Black South African, and those with low education attainment and low outreach exposure, innovative testing, and adherence strategies should be developed to improve the HIV cascade for South African transgender women.

fundingThe US President's Emergency Plan For AIDS Relief and US Centers for Disease Control and Prevention.

Indexed as

HIV-1HIV InfectionsTransgender PersonsAnti-Retroviral AgentsCitiesContinuity of Patient CareFemaleHumansMaleSouth AfricaSurveys and QuestionnairesAnti-Retroviral Agents

Identifiers

PMID37119825
OpenAlexW4367043159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.